There is abundant evidence in the literature which suggests, that chloramphenicol therapy in typhoid fever influences the antigenic character of S.typhi. Typhoid patients treated early in the disease with chloramphenicol do not produce, in most cases, antibodies to S.typhi. The rate of relapse in these patients is high and the incidence of carriers is not improved by treatment with this antibiotic. However, if typhoid vaccine is given, normal antibodies develop to a high titer.
| Identifer | oai:union.ndltd.org:LACETR/oai:collectionscanada.gc.ca:QMM.110166 |
| Date | January 1956 |
| Creators | Ciplijauskaite, Jurate E. |
| Contributors | Reed, R.W. (Supervisor) |
| Publisher | McGill University |
| Source Sets | Library and Archives Canada ETDs Repository / Centre d'archives des thèses électroniques de Bibliothèque et Archives Canada |
| Language | English |
| Detected Language | English |
| Type | Electronic Thesis or Dissertation |
| Format | application/pdf |
| Coverage | Doctor of Philosophy. (Department of Bacteriology and Immunology.) |
| Rights | All items in eScholarship@McGill are protected by copyright with all rights reserved unless otherwise indicated. |
| Relation | alephsysno: NNNNNNNNN, Theses scanned by McGill Library. |
Page generated in 0.0058 seconds